Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCQ908 (Pradigastat) Monotherapy in Hepatitis C
NCT01387958Phase 2Terminated
- Sponsor
- Novartis
- Start
- Jul 2011
- Primary completion
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pradigastat in hepatitis C (HCV), sponsored by Novartis. Started Jul 2011; status: terminated.
02
Drugs
pradigastat
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01387958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01387958.